tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Amanda Murphy, 13 are a BUY (100%).
Analyst Amanda Murphy, carries an average stock price target met ratio of 70.83% that have a potential upside of 33.84% achieved within 183 days. Previously, Amanda Murphy worked at BTIG.
Amanda Murphy’s has documented 27 price targets and ratings displayed on 8 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ADPT, Adaptive Biotechnologies Corp at 04-Nov-2021.
Analyst best performing recommendations are on FATE (FATE THERAPEUTICS).
The best stock recommendation documented was for ADPT (ADAPTIVE BIOTECHNOLOGIES CORP) at 7/23/2019. The price target of $46 was fulfilled within 23 days with a profit of $5.62 (13.92%) receiving and performance score of 6.05.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 30-Sep-2025
$22
$0.81 (3.82%)
$21
9 days ago
(29-Jun-2026)
4/4 (100%)
$0.6 (2.80%)
67
Buy Since 07-Oct-2020
$22
$1.04 (4.96%)
$22
21 days ago
(17-Jun-2026)
12/19 (63.16%)
$5.22 (31.11%)
231
Hold Since 09-Sep-2020
$18
$-2.96 (-14.12%)
$11
1 months 26 days ago
(12-May-2026)
12/16 (75%)
$4.37 (32.06%)
517
Buy Since 03-Aug-2023
$20
$-0.96 (-4.58%)
$10
8 months 2 days ago
(06-Nov-2025)
8/8 (100%)
$4.44 (28.53%)
204
Buy Since 21-Dec-2022
$20
$-0.96 (-4.58%)
$15
8 months 23 days ago
(15-Oct-2025)
14/14 (100%)
$2.89 (16.89%)
332
What Year was the first public recommendation made by Amanda Murphy?
